Scopus BioPharma's Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer

GlobeNewswireNov 7, 2023 09:15 ET

Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer

GlobeNewswireNov 2, 2023 09:15 ET

Nasdaq to Delist Shares of Waitr and Calithera Biosciences, Among Others

Seeking AlphaMar 1, 2023 18:26 ET

Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta

GlobeNewswireMar 1, 2023 16:17 ET

Scopus BioPharma (NASDAQ:SCPS) Shares Down 8.3%

Defense WorldJan 19, 2023 01:41 ET

Scopus BioPharma Inc. (NASDAQ:SCPS) Sees Significant Increase in Short Interest

Financial News LiveDec 28, 2022 18:41 ET